Clinical trial
Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
NCT00099567 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00099567 |
|---|---|
| Title | Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline |
| Official title | Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Paul Beeson Faculty Scholars Program University of California, San Francisco |
| Status | Completed |
| Study type | Observational |
| Conditions | Cognitive Decline |
| Enrollment | 2,632 |
| Start date | Jan 1, 1997 |
| Completion | Dec 1, 2002 |
| First posted | Dec 17, 2004 |
| Last update posted | Nov 1, 2005 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: